Literature DB >> 8654188

Interindividual variation in carboxylesterase levels in human liver microsomes.

M Hosokawa1, T Endo, M Fujisawa, S Hara, N Iwata, Y Sato, T Satoh.   

Abstract

Microsomal carboxylesterase activities in 12 human livers were determined using 10 kinds of carboxylesterase substrates (p-nitrophenylacetate, p-nitrophenylpropionate, p-nitrophenylbutyrate, butanilicaine, isocarboxazid, palmitoyl-coenzyme-A, malathion, clofibrate, acetanilide, and phenacetin). There were large individual differences in the 12 humans based on experimental results in the past several years in our laboratory. We found that all human liver microsomes have RH1-immunoreactive carboxylesterase, and the carboxylesterase content in liver also showed large individual differences. The RH1-immunoreactive carboxylesterase concentration correlated well with those of p-nitrophenylesters, clofibrate, butanilicaine, and isocarboxazid, and anti-RH1 immunoglobulin G strongly inhibited human liver hydrolase activity. These findings indicate that one major carboxylesterase isozyme that is immunoreactive with anti-RH1 in human liver microsomes has catalytic activity on major carboxylesterase substrates, and thus hydrolase activity in human liver depends on the expression level of this carboxylesterase isozyme. These observations should be useful in understanding the action of carboxylesterases on drug metabolism in humans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8654188

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  14 in total

1.  Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds.

Authors:  Karen L Jansen; Toby B Cole; Sarah S Park; Clement E Furlong; Lucio G Costa
Journal:  Toxicol Appl Pharmacol       Date:  2009-02-09       Impact factor: 4.219

2.  A Comprehensive Functional Assessment of Carboxylesterase 1 Nonsynonymous Polymorphisms.

Authors:  Xinwen Wang; Nada Rida; Jian Shi; Audrey H Wu; Barry E Bleske; Hao-Jie Zhu
Journal:  Drug Metab Dispos       Date:  2017-08-24       Impact factor: 3.922

3.  CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors.

Authors:  X Wang; G Wang; J Shi; J Aa; R Comas; Y Liang; H-J Zhu
Journal:  Pharmacogenomics J       Date:  2015-06-16       Impact factor: 3.550

Review 4.  The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.

Authors:  Toby B Cole; Karen Jansen; Sarah Park; Wan-Fen Li; Clement E Furlong; Lucio G Costa
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Examination of the carboxylesterase phenotype in human liver.

Authors:  Matthew K Ross; Abdolsamad Borazjani; Ran Wang; J Allen Crow; Shuqi Xie
Journal:  Arch Biochem Biophys       Date:  2012-04-16       Impact factor: 4.013

6.  Inhibition of Human Liver Carboxylesterase (hCE1) by Organophosphate Ester Flame Retardants and Plasticizers: Implications for Pharmacotherapy.

Authors:  Allison L Phillips; Heather M Stapleton
Journal:  Toxicol Sci       Date:  2019-07-03       Impact factor: 4.849

Review 7.  The role of human carboxylesterases in drug metabolism: have we overlooked their importance?

Authors:  S Casey Laizure; Vanessa Herring; Zheyi Hu; Kevin Witbrodt; Robert B Parker
Journal:  Pharmacotherapy       Date:  2013-02       Impact factor: 4.705

8.  Effects of methylphenidate on the aggressive behavior, serotonin and dopamine levels, and dopamine-related gene transcription in brain of male Nile tilapia (Oreochromis niloticus).

Authors:  Isabela Gertrudes Batalhão; Daína Lima; Ana Paula Montedor Russi; Camila Nomura Pereira Boscolo; Danilo Grunig Humberto Silva; Thiago Scremin Boscolo Pereira; Afonso Celso Dias Bainy; Eduardo Alves de Almeida
Journal:  Fish Physiol Biochem       Date:  2019-05-03       Impact factor: 2.794

9.  Sacubitril Is Selectively Activated by Carboxylesterase 1 (CES1) in the Liver and the Activation Is Affected by CES1 Genetic Variation.

Authors:  Jian Shi; Xinwen Wang; Jenny Nguyen; Audrey H Wu; Barry E Bleske; Hao-Jie Zhu
Journal:  Drug Metab Dispos       Date:  2016-01-27       Impact factor: 3.922

10.  Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic Polymorphisms.

Authors:  Jian Shi; Xinwen Wang; Rachel F Eyler; Yan Liang; Li Liu; Bruce A Mueller; Hao-Jie Zhu
Journal:  Basic Clin Pharmacol Toxicol       Date:  2016-07-21       Impact factor: 4.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.